期刊文献+

钙拮抗剂的世纪展望 被引量:4

下载PDF
导出
出处 《中国医刊》 CAS 2001年第10期20-23,共4页 Chinese Journal of Medicine
  • 相关文献

参考文献11

  • 1Pahor M,Psaty BM,Alderman MH,et al.Health outcome associated with calcium antagonists compared with other first-lineantihypertensive therapies: a meta-analysis of randomized controlled trials. Lancet,2000,356:1949-1954
  • 2Sleight P. Calcium antagonists during and after myocardial infarction. Drugs,1996,51(2) :216-225
  • 3Lecnen FHH. Regression of cardiac hypertrophy by 1,4 dihydropyridines inhypertensive patients. J Hypertens, 1998,16(Suppl 5): S9-S15
  • 4Schiffrin EL.Vascular protection with newer antihypertensive agents. J Hypertens,1998,16(Suppl 5): S25-S29
  • 5Zanchetti A, Rosei EA, Palu D, et al. The verapamil in hypertension andatherosclerosis study(VHAS): results of long-term randomized treatment with eitherverapamil or chlorthalidone on carotid intima media thickness. J Hypertens,1998,16:1667-1676
  • 6Lisheng L. Effects of hypertensive control on stroke incidence and fatality:reportfrom Syst-China and post-stroke antihypertensive treatment. J Hum Hypertens, 1996, 10(Suppl 1 ): S9-S11
  • 7Staessen JA, Thijis L, Fagard RH, et al. Calcium channel blockade andcardiovascular prognosis in the European trial on isolated systolic hypertension.Hypertension, 1998,32(3) :410-416
  • 8Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressurelowering and low-dose aspirin in patients with hypertension: principal results of theHypertension Optimal Treatment (HOT)randomized trial. Lancet, 1998,351 (9118): 1755-1762
  • 9Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patientsrandomized to double-blind treatment with long-acting calcium channel blocker or diureticin the international Nifedipine GITS Study: Intervention as a Goal in HypertensionTreatment (INSIGHT) . Lancet,2000,356: 366-372
  • 10Hansson L, Hedner T, Lund-Johansen P, et al. Randomised trial of effects ofcalcium antagonists compared with diuretics and β-blockers on cardiovascular morbidityand mortality in hypertension: the Nordic Diltiazem(NORDIL) Study. Lancet, 2000,256:359-365

同被引文献23

  • 1王红锋,宋大菊,路军英,贾四杰.尼莫地平对蛛网膜下腔出血并发脑血管痉挛的防治作用(附57例报告)[J].中风与神经疾病杂志,1995,12(4):237-237. 被引量:13
  • 2黄如训 梁秀龄 等.临床神经病学[M].北京:人民卫生出版社,1999.32-33.
  • 3Raicevic R,Jleksic P,Sano K. Role of nimodipine in the therapy of subarachnoid and intraeerebral hemorrhage[J]. Vojnosanit Pregl, 1999,56(6):593-598.
  • 4Egge A,Waterloo K,Sjoholm H,et al. Systematic review of the prevention of delayed isehemic neurological deficits with hyper- tension, hypervolcmia, and hemodilution thetapy following sub- arachnoid hemorrhage[J].JNeurosurg, 2003,98(5) : 978-984.
  • 5Smith ML,AbrahamsJM,Chandela S,et al. Subarachnoid hem orrhage on computed tomography scanning and the develop ment of computed vasospuasm~the Fisher grade revisited [J]. Surg Neurol,2005,63(3):229-235.
  • 6Raicevic R,Jleksic P,Sano K. Role of nimodipine in the therapy of subarachnoid and intraeerebral hemorrhage[J].Vojnosanit Pregl, 1999,56(6) :593-598.
  • 7韩仲岩.临床脑血管疾病学[M].上海:上海科学技术出版社,1994.662.
  • 8Raicevic R,Jleksic P,Sano K.Role of nimodipine in the therapy of subarachnoid and intracerebral hemorrhage.Vojnosanit Pregl,1999,56:593-598.
  • 9董利.尼莫地平治疗蛛网膜下腔出血后脑血管痉挛的疗效观察[J].淮海医药,2009,27(3):252-253. 被引量:2
  • 10冯金福,段传志,李西锋,法志强,柯以铨,张世忠,姜晓丹.蛛网膜下腔出血患者迟发性脑血管痉挛相关因素的临床分析[J].中华神经医学杂志,2009,8(5):509-512. 被引量:19

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部